Integra LifeSciences Holdings Corporation (NASDAQ:IART), is not the largest company out there, but it saw a decent share price growth of 15% on the NASDAQGS over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's take a look at Integra LifeSciences Holdings's outlook and value based on the most recent financial data to see if the opportunity still exists.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
Is Integra LifeSciences Holdings Still Cheap?
According to our valuation model, Integra LifeSciences Holdings seems to be fairly priced at around 10% below our intrinsic value, which means if you buy Integra LifeSciences Holdings today, you'd be paying a reasonable price for it. And if you believe the company's true value is $14.08, then there isn't much room for the share price grow beyond what it's currently trading. So, is there another chance to buy low in the future? Given that Integra LifeSciences Holdings's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us an opportunity to buy later on. This is based on its high beta, which is a good indicator for share price volatility.
See our latest analysis for Integra LifeSciences Holdings
Can we expect growth from Integra LifeSciences Holdings?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. In the upcoming year, Integra LifeSciences Holdings' earnings are expected to increase by 83%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.
What This Means For You
Are you a shareholder? It seems like the market has already priced in IART's positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?